Streetbeat News

Earnings

CVAC

CureVac reported a Q1 2024 pre-tax loss of €69.9 million, compared to a loss of €57.4 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:07 am

CLBT

Cellebrite expects to drive solid Annual Recurring Revenue (ARR) and revenue expansion in Q2, projecting revenue between $90M and $94M, surpassing the estimated $89.405M.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:07 am

NVDA

NWSA

QQQ

SNOW

SPY

VFC

ZUO

Wall Street is set for a strong open driven by Nvidia's positive earnings, with key economic data and a Federal Reserve official's speech also in focus. Nvidia's stock surged over 6.6% in premarket trading, while other notable movements include Snowflake, V.F. Corporation, and Zuora. Analysts suggest a bullish near-term market outlook, but caution on the potential impact of weak economic data.

Portfolio Pulse from Shanthi Rexaline

May 23, 2024 | 11:07 am

SOTK

Sono-Tek (NASDAQ:SOTK) reported Q4 earnings per share of $0.01, meeting analyst expectations. The company also reported quarterly sales of $4.77 million, a 30.38% increase from the same period last year. Cash and equivalents as of February 28 totaled $11.8 million.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:06 am

CVAC

CureVac reported Q1 2024 sales of €12.400 million, surpassing the estimated €12.030 million.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:06 am

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q1 2024 earnings of $0.08 per share, beating the analyst estimate of $0.06 by 33.33%. Sales were $89.582 million, surpassing the $87.757 million estimate and marking a 25.76% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:03 am

BJ

BJ's Wholesale Club reported Q1 2024 adjusted EPS of $0.85, beating the estimate of $0.83. Total revenues were $4.918 billion, surpassing the expected $4.831 billion.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:00 am

TITN

Titan Machinery has lowered its FY25 EPS outlook to $2.25-$2.75 from the previous range of $3.00-$3.50, which is below the estimate of $3.18. Additionally, the company has reduced its Australia revenue outlook to $240M-$260M from the prior view of $250M-$270M.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:58 am

MDT

Medtronic has forecasted its fiscal year 2025 adjusted EPS to be in the range of $5.40 to $5.50, which aligns closely with the consensus estimate of $5.45.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:53 am

TITN

Titan Machinery's CEO Bryan Knutson has highlighted a challenging market environment with softening demand and excess inventory. Lower net farm income and higher interest rates are affecting farmers' equipment purchasing decisions. The company is focusing on customer care, managing fixed overhead, and aligning inventory with demand to improve financial results.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:53 am